Nocardia Rubra Cell Wall Skeleton for Stem Cell Survival and Expansion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge lies in the limited availability and difficult culture of adult stem cells, particularly adipose-derived mesenchymal stem cells (Ad-MSCs), which face poor survival rates due to adverse conditions post-transplantation, hindering their therapeutic effectiveness in regenerative medicine.
Innovation Solution
The use of Nocardia rubra cell wall skeleton, derived from Nocardia rubra bacteria, to regulate the proliferation and differentiation of adult stem cells, enhancing their survival and therapeutic potential through formulations like ointments, creams, and medical devices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If adult stem cells are used for cell replacement therapy, then ethical issues are avoided and differentiation potential is maintained, but the number of stem cells is limited and long-term culture expansion is difficult
Solution Approach 1:
The patent introduces Nocardia rubra cell wall skeleton as an intermediary substance that mediates between the limited stem cell supply and the need for large-scale cell expansion. This extracellular matrix component serves as a bridge that enables serum-free culture conditions to support stem cell proliferation without requiring additional stem cell sources or compromising ethical considerations.
Solution Approach 2:
The patent changes the culture medium parameters by replacing serum-containing media with serum-free media supplemented with Nocardia rubra cell wall skeleton. This parameter change transforms the culture conditions to enable long-term stem cell expansion while maintaining cell quality and differentiation potential, thereby increasing the quantity of usable stem cells.
2Productivity
If stem cells are transplanted into damaged tissue, then cell replacement therapy is achieved, but adverse conditions such as hypoxia, inflammation, and oxidative stress lead to poor cell survival
Solution Approach 1:
The patent applies Nocardia rubra cell wall skeleton to stem cells before transplantation as a preliminary protective action. This pre-treatment allows stem cells to acclimate to adverse conditions and pre-activate survival mechanisms, thereby improving cell survival rates when the cells are subsequently exposed to hypoxia, inflammation, and oxidative stress in the damaged tissue environment.
Solution Approach 2:
The Nocardia rubra cell wall skeleton acts as a protective cushion that shields stem cells from the harsh transplantation environment. This extracellular matrix component provides beforehand cushioning against oxidative stress and inflammatory damage, allowing cells to withstand adverse conditions that would otherwise lead to poor survival rates.
Data Source
AI summary
The present disclosure relates to a use of Nocardia rubra cell wall skeleton in regenerative medicine, and in particular, to a use of Nocardia rubra (especially the cell wall skeleton thereof) in the following aspects: promoting proliferation, growth, differentiation and migration of stem cells, and improving the survival rate of the stem cells, wherein the stem cells are selected from: adult stem cells, iPSCs, and mesenchymal stem cells.